Articles with "1007 pet" as a keyword



Photo by nci from unsplash

Rib Fractures Mimicking Bone Metastases in 18F-PSMA-1007 PET/CT for Prostate Cancer.

Sign Up to like & get
recommendations!
Published in 2019 at "Clinical Nuclear Medicine"

DOI: 10.1097/rlu.0000000000002354

Abstract: Prostate-specific membrane antigen (PSMA) is a membrane glycoprotein that is overexpressed in prostate cancer cells. It is also expressed in other normal tissues and several other malignant and benign diseases. We present a case of… read more here.

Keywords: psma 1007; prostate cancer; psma; 1007 pet ... See more keywords
Photo by jonasvincentbe from unsplash

Comparison of 18F-PSMA-1007 PET/CT With 68Ga-PSMA-11 PET/CT for Initial Staging in Intermediate- and High-Risk Prostate Cancer

Sign Up to like & get
recommendations!
Published in 2022 at "Clinical Nuclear Medicine"

DOI: 10.1097/rlu.0000000000004430

Abstract: Purpose This study aimed to compare 18F-PSMA-1007 PET/CT with 68Ga-PSMA-11 PET/CT for initial staging in intermediate- and high-risk prostate cancer (PCa) patients. Methods Forty treatment-naive, biopsy-proven, intermediate- or high-risk PCa patients were prospectively recruited. Each… read more here.

Keywords: pet; 68ga psma; psma; 1007 pet ... See more keywords
Photo by jonasvincentbe from unsplash

Evaluation of a radiomics nomogram derived from Fluoride-18 PSMA-1007 PET/CT for risk stratification in newly diagnosed prostate cancer

Sign Up to like & get
recommendations!
Published in 2022 at "Frontiers in Oncology"

DOI: 10.3389/fonc.2022.1018833

Abstract: Objective The aim of this study was to evaluate the performance of Fluoride-18 (18F)-PSMA-1007-PET/CT radiomics for the tumor malignancy and clinical risk stratification in primary prostate cancer (PCa). Materials and Methods A total of 161… read more here.

Keywords: psma 1007; pet; risk stratification; 1007 pet ... See more keywords
Photo by europeana from unsplash

Detection rate of fluorine-18 prostate-specific membrane antigen-1007 PET/CT for prostate cancer in primary staging and biochemical recurrence with different serum PSA levels: A systematic review and meta-analysis

Sign Up to like & get
recommendations!
Published in 2022 at "Frontiers in Oncology"

DOI: 10.3389/fonc.2022.911146

Abstract: Background We performed a systematic review and meta-analysis to evaluate the detection rate (DR) of fluoro-prostate-specific membrane antigen (18F-PSMA-1007) PET/CT in patients with different serum prostate-specific antigen (PSA) levels in the setting of primary staging… read more here.

Keywords: psma 1007; 18f psma; prostate; 1007 pet ... See more keywords

Recurrent Prostate Cancer Diagnostics with 18F-PSMA-1007 PET/CT: A Systematic Review of the Current State

Sign Up to like & get
recommendations!
Published in 2022 at "Diagnostics"

DOI: 10.3390/diagnostics12123176

Abstract: Background: Early diagnosis of recurrent prostate cancer is a cornerstone for further adequate therapy planning. Therefore, clinical practice and research still focuses on diagnostic tools that can detect prostate cancer in early recurrence when it… read more here.

Keywords: psma 1007; 18f psma; prostate cancer; 1007 pet ... See more keywords